PHARMAESSENTIA CORP.
Area: Pharmaceutical and Medical Devices
Booth No: R207
Website: https://hq.pharmaessentia.com/tw
Exhibitor Profile
Compared with similar drugs on the market, the long-acting, mono-pegylated proline interferon with improved pharmacokinetic properties allowing once every two weeks administration offering improved tolerability and convenience. The marketing authorization for PharmaEssentia’s Ropeginterferon alfa-2b for treatment of Polycythemia Vera (PV) is granted by EMA in February 2019, Taiwan in May 2020 and FDA in November 2021.
Brands
Ropeginterferon alfa-2b
Exhibit Products
Exhibitors you may be interested in
Highest Rated
-
SUNWAY SCIENTIFIC CORPORATION
-
MITEKLAB CO., LTD.
-
RELIANCE BIOSCIENCES INCORPORATED
-
UHLMANN SINGAPORE LLP
-
TAIMED BIOLOGICS INC.
-
YOKOGAWA TAIWAN CORPORATION KAOHSIUNG OFFICE
-
BUCHI TAIWAN CO., LTD.
-
COUNCIL OF AGRICULTURE, EXECUTIVE YUAN
-
MOST FORUM
-
NATIONAL HEALTH RESEARCH INSTITUTES
-
MINISTRY OF SCIENCE AND TECHNOLOGY
-
INNOVATION HEADQUARTERS, NATIONAL CHENG KUNG UNIVERSITY (IHQ NCKU)
-
TAIPEI MEDICAL UNIVERSITY
-
HSINCHU SCIENCE PARK BUREAU, MINISTRY OF SCIENCE AND TECHNOLOGY
-
NATIONAL TAIWAN UNIVERSITY
-
CHINA MEDICAL UNIVERSITY
-
SOUTHERN TAIWAN SCIENCE PARK BUREAU, MINISTRY OF SCIENCE AND TECHNOLOGY
-
MINISTRY OF HEALTH AND WELFARE
-
BIOMEDICAL TRANSLATION RESEARCH CENTER, ACADEMIA SINICA (NATIONAL BIOTECHNOLOGY RESEARCH PARK)
-
INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
-
TAIPEI CITY GOVERNMENT
-
NATIONAL CHUNG HSING UNIVERSITY
-
CENTRAL TAIWAN SCIENCE PARK BUREAU, MINISTRY OF SCIENCE AND TECHNOLOGY
-
E2JOY CORPORATION
-
YENCHEN MACHINERY CO., LTD.
-
THE CENTER FOR TECHNOLOGY TRANSFER AND RESOURCES INTEGRATION, FU JEN CATHOLIC UNIVERSITY
-
TAIWAN GARMENT INDUSTRY ASSOCIATION
-
DEVELOPMENT CENTER FOR BIOTECHNOLOGY
-
CHANG GUNG UNIVERSITY
-
NATIONAL YANG MING CHIAO TUNG UNIVERSITY(NYCU CAIC)
